Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D0D5AI
|
|||
Drug Name |
A1-10438
|
|||
Synonyms |
3-[4-(2-tert-butylphenyl)piperazin-1-yl]-3-oxopropanoic acid; SCHEMBL631591; CHEMBL3644468; BJJSTQNQWBMPNN-UHFFFAOYSA-N; BDBM135827; US8853215, 9; A1-10438
Click to Show/Hide
|
|||
Drug Type |
Small molecular drug
|
|||
Structure |
Download2D MOL |
|||
Formula |
C17H24N2O3
|
|||
Canonical SMILES |
CC(C)(C)C1=CC=CC=C1N2CCN(CC2)C(=O)CC(=O)O
|
|||
InChI |
1S/C17H24N2O3/c1-17(2,3)13-6-4-5-7-14(13)18-8-10-19(11-9-18)15(20)12-16(21)22/h4-7H,8-12H2,1-3H3,(H,21,22)
|
|||
InChIKey |
BJJSTQNQWBMPNN-UHFFFAOYSA-N
|
|||
PubChem Compound ID |
Target and Pathway | Top | |||
---|---|---|---|---|
Target(s) | Plasma retinol-binding protein (RBP4) | Target Info | Inhibitor | [1] |
Target's Patent Info | Plasma retinol-binding protein (RBP4) | Target's Patent Info | [1] |
References | Top | |||
---|---|---|---|---|
REF 1 | Derivatives of N-acyl-N-phenylpiperazine useful (inter alia) for the prophylaxis or treatment of diabetes. US8853215. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.